These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 23817382)

  • 1. Relationship between trough plasma and epithelial lining fluid concentrations of voriconazole in lung transplant recipients.
    Heng SC; Snell GI; Levvey B; Keating D; Westall GP; Williams TJ; Whitford H; Nation RL; Slavin MA; Morrissey O; Kong DC
    Antimicrob Agents Chemother; 2013 Sep; 57(9):4581-3. PubMed ID: 23817382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intrapulmonary penetration of voriconazole in patients receiving an oral prophylactic regimen.
    Capitano B; Potoski BA; Husain S; Zhang S; Paterson DL; Studer SM; McCurry KR; Venkataramanan R
    Antimicrob Agents Chemother; 2006 May; 50(5):1878-80. PubMed ID: 16641467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective, observational study of voriconazole therapeutic drug monitoring among lung transplant recipients receiving prophylaxis: factors impacting levels of and associations between serum troughs, efficacy, and toxicity.
    Mitsani D; Nguyen MH; Shields RK; Toyoda Y; Kwak EJ; Silveira FP; Pilewski JM; Crespo MM; Bermudez C; Bhama JK; Clancy CJ
    Antimicrob Agents Chemother; 2012 May; 56(5):2371-7. PubMed ID: 22330924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioavailability and population pharmacokinetics of voriconazole in lung transplant recipients.
    Han K; Capitano B; Bies R; Potoski BA; Husain S; Gilbert S; Paterson DL; McCurry K; Venkataramanan R
    Antimicrob Agents Chemother; 2010 Oct; 54(10):4424-31. PubMed ID: 20679503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma levels of voriconazole administered via a nasogastric tube to critically ill patients.
    Mohammedi I; Piens MA; Padoin C; Robert D
    Eur J Clin Microbiol Infect Dis; 2005 May; 24(5):358-60. PubMed ID: 15875225
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical outcomes of lung-transplant recipients treated by voriconazole and caspofungin combination in aspergillosis.
    Thomas A; Korb V; Guillemain R; Caruba T; Boussaud V; Billaud E; Prognon P; Begué D; Sabatier B
    J Clin Pharm Ther; 2010 Feb; 35(1):49-53. PubMed ID: 20175811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bronchopulmonary disposition of intravenous voriconazole and anidulafungin given in combination to healthy adults.
    Crandon JL; Banevicius MA; Fang AF; Crownover PH; Knauft RF; Pope JS; Russomanno JH; Shore E; Nicolau DP; Kuti JL
    Antimicrob Agents Chemother; 2009 Dec; 53(12):5102-7. PubMed ID: 19770284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic drug monitoring of voriconazole in children.
    Chen J; Chan C; Colantonio D; Seto W
    Ther Drug Monit; 2012 Feb; 34(1):77-84. PubMed ID: 22210097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma concentrations of voriconazole in falcons.
    Schmidt V; Demiraj F; Di Somma A; Bailey T; Ungemach FR; Krautwald-Junghanns ME
    Vet Rec; 2007 Aug; 161(8):265-8. PubMed ID: 17720963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Voriconazole plasma levels in children are highly variable.
    Spriet I; Cosaert K; Renard M; Uyttebroeck A; Meyts I; Proesmans M; Meyfroidt G; de Hoon J; Verbesselt R; Willems L
    Eur J Clin Microbiol Infect Dis; 2011 Feb; 30(2):283-7. PubMed ID: 20963460
    [No Abstract]   [Full Text] [Related]  

  • 11. Monitoring plasma voriconazole levels may be necessary to avoid subtherapeutic levels in hematopoietic stem cell transplant recipients.
    Trifilio S; Pennick G; Pi J; Zook J; Golf M; Kaniecki K; Singhal S; Williams S; Winter J; Tallman M; Gordon L; Frankfurt O; Evens A; Mehta J
    Cancer; 2007 Apr; 109(8):1532-5. PubMed ID: 17351937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of voriconazole following intravenous and oral administration and body fluid concentrations of voriconazole following repeated oral administration in horses.
    Colitz CM; Latimer FG; Cheng H; Chan KK; Reed SM; Pennick GJ
    Am J Vet Res; 2007 Oct; 68(10):1115-21. PubMed ID: 17916020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Highly variable plasma concentrations of voriconazole in pediatric hematopoietic stem cell transplantation patients.
    Bartelink IH; Wolfs T; Jonker M; de Waal M; Egberts TC; Ververs TT; Boelens JJ; Bierings M
    Antimicrob Agents Chemother; 2013 Jan; 57(1):235-40. PubMed ID: 23114771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic drug monitoring of voriconazole after intravenous administration in infants and children with primary immunodeficiency.
    Gerin M; Mahlaoui N; Elie C; Lanternier F; Bougnoux ME; Blanche S; Lortholary O; Jullien V
    Ther Drug Monit; 2011 Aug; 33(4):464-6. PubMed ID: 21743382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Voriconazole pharmacokinetics and pharmacodynamics in children.
    Neely M; Rushing T; Kovacs A; Jelliffe R; Hoffman J
    Clin Infect Dis; 2010 Jan; 50(1):27-36. PubMed ID: 19951112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serial plasma voriconazole concentrations after allogeneic hematopoietic stem cell transplantation.
    Trifilio SM; Yarnold PR; Scheetz MH; Pi J; Pennick G; Mehta J
    Antimicrob Agents Chemother; 2009 May; 53(5):1793-6. PubMed ID: 19223632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of sustained high plasma trough concentration of voriconazole with the incidence of hepatotoxicity.
    Suzuki Y; Tokimatsu I; Sato Y; Kawasaki K; Sato Y; Goto T; Hashinaga K; Itoh H; Hiramatsu K; Kadota J
    Clin Chim Acta; 2013 Sep; 424():119-22. PubMed ID: 23747486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Voriconazole pharmacokinetic variability in cystic fibrosis lung transplant patients.
    Berge M; Guillemain R; Boussaud V; Pham MH; Chevalier P; Batisse A; Amrein C; Dannaoui E; Loriot MA; Lillo-Le Louet A; Billaud EM
    Transpl Infect Dis; 2009 Jun; 11(3):211-9. PubMed ID: 19302272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of voriconazole during continuous venovenous haemodiafiltration.
    Fuhrmann V; Schenk P; Jaeger W; Miksits M; Kneidinger N; Warszawska J; Holzinger U; Kitzberger R; Thalhammer F
    J Antimicrob Chemother; 2007 Nov; 60(5):1085-90. PubMed ID: 17855725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Voriconazole concentrations and outcome of invasive fungal infections.
    Miyakis S; van Hal SJ; Ray J; Marriott D
    Clin Microbiol Infect; 2010 Jul; 16(7):927-33. PubMed ID: 19845698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.